CLEVELAND, Ohio - A new study shows that drugs commonly used to treat erectile dysfunction, such as Viagra, may reduce a person’s risk of developing Alzheimer's disease by up to two-thirds.
According to the study, supported by the National Institutes of Health and published in "Naturing Aging" earlier this month, people who took the drug sildenafil (also known by brand names including Viagra and Revatio) were less likely to develop Alzheimer’s disease.
Sildenafil is FDA-approved to treat erectile dysfunction and pulmonary hypertension.A team of researchers, led by Dr. Feixiong Cheng at the Cleveland Clinic, analyzed data on more than 7 million U.S.